AZN

ASTRAZENECA PLC AZN

NYSEMega CapHealthcare
InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro quality score

Rank #47 of 2,925TOP 5%

Why it scores 79Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$58.74B

Quarter to Dec 31

Net income

$10.22B

Quarter to Dec 31

Free cash flow

$11.77B

Quarter to Dec 31

Operating margin

23.4%

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$196.19B total
Evelyn Partners Group Ltd
$41.52B--
INVESTOR AB
$9.78B0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$8.47B+0.8%
Capital International Investors
$6.49B+0.5%
NORGES BANK
$6.33B--
Capital World Investors
$5.63B+6.4%
FMR LLC
$5.42B-2.4%
WELLINGTON MANAGEMENT GROUP LLP
$5.36B+20.2%
Legal & General Group Plc
$4.82B-0.4%
JPMORGAN CHASE & CO
$3.67B+3.3%
VANGUARD ASSET MANAGEMENT, Ltd
$3.49B+1.0%
PRIMECAP MANAGEMENT CO/CA/
$3.43B-0.7%
BANK OF AMERICA CORP /DE/
$3.35B-7.2%
PRUDENTIAL PLC
$3.19B+3.3%
PRICE T ROWE ASSOCIATES INC /MD/
$3.15B-14.7%
Amundi
$3.11B+6.7%
FRANKLIN RESOURCES INC
$3.11B-7.2%
VANGUARD FIDUCIARY TRUST CO
$2.48B+0.7%
DEUTSCHE BANK AG\
$2.40B+4.2%
Jupiter Topco LLC
$2.22B--
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt
$2.19B-9.4%
Fisher Asset Management, LLC
$2.11B+2.8%
AVIVA PLC
$2.04B-1.7%
ROYAL BANK OF CANADA
$1.98B+0.4%
Invesco Ltd.
$1.93B+0.7%
See all 1,516 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/AZN

Earnings Per Share

13fpro.ai/company/AZN

Loading ratio trend…

AZN key financials by period

Reported revenue, net income and operating margin by fiscal year, from ASTRAZENECA PLC's annual filings on SEC EDGAR.

ASTRAZENECA PLC reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$58.7B$10.2B23.4%
FY 2024$54.1B$7.0B18.5%
FY 2023$45.8B$6.0B17.9%
FY 2022$44.4B$3.3B8.5%
FY 2021$37.4B$112.0M2.8%
FY 2020$26.6B$3.2B19.4%
Source: AZN filings on SEC EDGAR →

Companies similar to AZN

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

AZN insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

Congress trading in AZN

17 transactions in AZN reported by 7 members of Congress under the STOCK Act, most recent trade Dec 18, 2025. Reported transactions, not recommendations.

All Congress stock trades →

About ASTRAZENECA PLC (AZN): stock profile, AI score and financials

ASTRAZENECA PLC (AZN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AZN at 78.7/100 on a composite quality score built from its SEC filings, placing it at rank #47 of 2,925 stocks — the top 5% of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), ASTRAZENECA PLC reports quarterly revenue of $58.7B, net income of $10.2B, an operating margin of 23.4%. Top institutional holders of AZN by reported 13-F value include Evelyn Partners Group Ltd, INVESTOR AB, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. AZN trades on the NYSE exchange and files with the SEC under CIK 901832. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AZN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ASTRAZENECA PLC directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 901832 →